United States · FDA National Drug Code directory

Docusate Sodium and Sennosides

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
35916-0454_47db8971-4012-5504-e063-6294a90afd37
Product NDC
35916-0454
Form
CAPSULE, GELATIN COATED
Composition / generic term
Docusate Sodium and Sennosides
Labeler
SOFTGEL HEALTHCARE PRIVATE LIMITED
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20240622
Source listing expiry
20271231

Source-listed ingredients

  • SENNOSIDES — 8.6 mg/1
  • DOCUSATE SODIUM — 50 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 500 CAPSULE, GELATIN COATED in 1 BOTTLE (35916-0454-1) · 35916-0454-1

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →